Shares of Diploma PLC (LON:DPLM – Get Rating) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 2,579.80 ($31.61) and traded as high as GBX 2,790 ($34.19). Diploma shares last traded at GBX 2,784 ($34.11), with a volume of 91,733 shares traded.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on the company. Shore Capital reaffirmed a “buy” rating on shares of Diploma in a research report on Thursday, July 21st. JPMorgan Chase & Co. cut their price target on Diploma from GBX 2,450 ($30.02) to GBX 2,100 ($25.73) and set an “underweight” rating on the stock in a research report on Wednesday, June 29th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 3,360 ($41.17) price target on shares of Diploma in a research report on Tuesday, July 26th. Royal Bank of Canada raised Diploma to a “sector perform” rating and cut their price target for the stock from GBX 2,600 ($31.86) to GBX 2,450 ($30.02) in a research report on Tuesday, May 17th. Finally, Barclays reaffirmed an “overweight” rating and set a GBX 3,290 ($40.31) price target on shares of Diploma in a research report on Friday, July 22nd. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of GBX 2,940 ($36.02).
Diploma Price Performance
The company has a current ratio of 2.37, a quick ratio of 1.45 and a debt-to-equity ratio of 73.00. The stock has a market capitalization of £3.47 billion and a price-to-earnings ratio of 4,718.64. The stock has a 50-day moving average price of GBX 2,431.23 and a 200 day moving average price of GBX 2,579.80.
Diploma Cuts Dividend
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, rest of Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies clinical diagnostics instrumentation and products, consumables, specialty surgical devices, and related consumables and services to public hospitals, private clinics, pathology laboratories, scientific research, and medical segments; surgical equipment for hospital operating rooms; and distributes laboratory diagnostics, specialty medical devices, devices, equipment, and patient monitoring technologies used in operating theatres, as well as medically supervised nutrition.
- Is It Time to Take a Ride on Cedar Fair Stock?
- Time To Take A Serious Look At Nikola Stock As Production Starts
- These Are The Top Insider Buying Stocks For July
- Chipotle Mexican Grill Or Shake Shak? Which Is The Tastier Play
- Activision Blizzard Banks On A Flurry Of New Content
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.